跳至主要内容
临床试验/JPRN-UMIN000001281
JPRN-UMIN000001281未知未知

Strategic reduction of joint destruction in rheumatoid arthritis - Strategic reduction of joint destruction in rheumatoid arthritis (ZERO-J study)

School of Medicine, University of Occupational and Environmental Health, Japan0 个研究点目标入组 120 人开始时间: 2008年7月31日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who met the following criteria are excluded. 1. patients with contra-indication to MTX 2. patients with contra-indication to TNF-inhibitors 3. patients who are not appropriate to the study by a doctor's judgement

研究者

发起方
School of Medicine, University of Occupational and Environmental Health, Japan

相似试验

已完成
不适用
Prevention of cartilage destruction in rheumatoid arthritis by etanercept (PRECEPT study)Rheumatoid arthritis
JPRN-UMIN000001798Team RA, Rheumatosurgery, Osaka City University Medical School100
进行中(未招募)
不适用
Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease.
EUCTR2009-010955-29-NLDivision of Clinically Immunology and Rheumatology, AMC
进行中(未招募)
1 期
Treatment tapering in oligoarticular or rheumatoid factor negative polyarticular Juvenile Idiopathic Arthritis with inactive disease on biologic therapy - AJIBIOREMPatients with oligoarticular onset or rheumatoid factor negative polyarticular JIA followed in tertiary care center for paediatric rheumatology.MedDRA version: 19.0Level: PTClassification code 10059176Term: Juvenile idiopathic arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-000312-15-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)230
已完成
不适用
Suppress the joint destruction in clinical remission patients who have active synovitis of ultrasonographic assessment by increasing the dose of methotrexaterheumatoid arthritis
JPRN-UMIN000009535Osaka City University Medical School134
进行中(未招募)
不适用
To treat contractures that have come back when they were previously successfully treated with AA4500 in a prior clinical studyDupuytren's contractureMedDRA version: 14.1Level: PTClassification code 10013872Term: Dupuytren's contractureSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2011-005065-21-SEAuxilium UK Limited150